MedPath

Sustained released intravitreal implants(University of Kentucky)

Generic Name
Sustained released intravitreal implants(University of Kentucky)

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Phase 1
Recruiting
Conditions
Geographic Atrophy
Age-Related Macular Degeneration
Interventions
First Posted Date
2023-12-11
Last Posted Date
2025-04-11
Lead Sponsor
University of Kentucky
Target Recruit Count
30
Registration Number
NCT06164587
Locations
🇺🇸

The Maine Eye Center, Portland, Maine, United States

🇺🇸

Oregon Eye Consultants, Cascade Medical Research, Eugene, Oregon, United States

🇺🇸

Ophthalmology LTD, Sioux Falls, South Dakota, United States

and more 2 locations

Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects with Diabetic Macular Edema

Phase 1
Completed
Conditions
Diabetic Macular Edema
Interventions
First Posted Date
2023-01-26
Last Posted Date
2024-11-01
Lead Sponsor
Michelle Abou-Jaoude
Target Recruit Count
1
Registration Number
NCT05699759
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath